Press releases

Transaction oversubscribed more than tenfold

Stuttgart, 20 December 2011. Today the Supervisory Board of Celesio AG appointed Marion Helmes the new Chief Financial Officer of the company, effective from 1 January 2012. In this role, she will be responsible for Finance and Treasury, Controlling, Accounting, Tax, Human Resources and IT. Most recently, Marion Helmes was member of the management board (CFO) at Q-Cells AG, Bitterfeld-Wolfen. At Celesio, she is replacing Christian Holzherr, who left the company as of 30 November 2011 on his own initiative.

• Pharmaceutical wholesale is set to expand expertise across complete logistics chain including specialist distribution
• With innovative service and shop concepts Celesio aims to become partner of first choice for pharmacies in Europe
• Good opportunities for expansion in growth markets such as Brazil, Latin America and the Middle East
• Management board examining sale of Manufacturer Solutions
• Operational Excellence Programme will sustainably increase competitiveness and secure turnaround in earnings already in 2012
• Realignment assures return to sustainably profitable growth

Why he has decided to relinquish his mandate as Chairman of the Supervisory Board of Metro AG

Internal solution for key position found again – employer attractiveness to be strengthened further

• Majority shareholding of 60 per cent in Oncoprod Group, a specialty pharmaceutical distributor with a focus on highly complex medicines, e.g. against cancer
• Building up a leading position in the growth market Brazil

• Celesio and Medco mutually agree to terminate the collaboration
• Medco will assume full ownership and operational control of the pan-European healthcare venture; delivering new healthcare solutions
• Celesio will continue with its existing activities to improve healthcare for patients with chronic or complex diseases